The shifting pharmaceutical sector presents unique hurdles and prospects. Advanced technologies, such as synthetic intelligence and precision medicine, are modifying medication discovery and administration. Furthermore, rising pressure on affordability and governmental processes necessitate a careful tactic from firms. Successfully navigating this